Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

49.19 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	510
Open	49.19
Bid (Size)	45.85 (100)
Ask (Size)	50.90 (600)
Prev. Close	49.19
Today's Range	49.19 - 49.19
52wk Range	27.07 - 51.62
Shares Outstanding	94,873,407
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Scholar Rock Q1 Earnings Call Highlights ↗

May 08, 2026

Scholar Rock (NASDAQ:SRRK) said the U.S. Food and Drug Administration has accepted for review its resubmitted Biologics License Application for apitegromab, the company’s investigational treatment for...

Via MarketBeat

Scholar Rock (SRRK) Q1 2026 Earnings Transcript ↗

May 08, 2026

Scholar Rock (SRRK) Q1 2026 Earnings Transcript

Via The Motley Fool

Performance

YTD	+14.9%	+14.9%
1 Month	-0.7%	-0.7%
3 Month	+3.3%	+3.3%
6 Month	+59.8%	+59.8%
1 Year	+51.5%	+51.5%

More News

Scholar Rock (SRRK) Q1 Loss Narrows In Line Awaits PDUFA Decision ↗

May 07, 2026

Via Chartmill

Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights

May 07, 2026

From Scholar Rock

Via Business Wire

Scholar Rock Holding Corp (NASDAQ:SRRK) Posts Q4 Loss, Awaits Apitegromab Approval in 2026 ↗

March 03, 2026

Via Chartmill

Scholar Rock to Present at the BofA Securities 2026 Health Care Conference

April 29, 2026

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 17, 2026

From Scholar Rock

Via Business Wire

Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026

April 16, 2026

From Scholar Rock

Via Business Wire

Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

March 31, 2026

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 13, 2026

From Scholar Rock

Via Business Wire

CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

March 03, 2026

From Scholar Rock

Via Business Wire

Scholar Rock (SRRK) Q4 2025 Earnings Transcript ↗

March 03, 2026

Via The Motley Fool

Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million ↗

February 22, 2026

Via The Motley Fool

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% ↗

February 22, 2026

Via The Motley Fool

Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year ↗

February 22, 2026

Via The Motley Fool

Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 ↗

February 22, 2026

Via The Motley Fool

Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% ↗

February 22, 2026

Via The Motley Fool

Scholar Rock to Present at Upcoming Investor Conferences

February 18, 2026

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 13, 2026

From Scholar Rock

Via Business Wire

Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

February 10, 2026

From Scholar Rock

Via Business Wire

Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 ↗

February 01, 2026

Via The Motley Fool

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

From Scholar Rock

Via Business Wire

Scholar Rock Highlights 2026 Strategic Priorities

January 12, 2026

From Scholar Rock, Inc.

Via Business Wire

Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 05, 2026

From Scholar Rock, Inc.

Via Business Wire

Nasdaq Bears Dig In: Short Interest Hits Record 18.38 Billion Shares Amid Valuation Anxiety

December 24, 2025

Via MarketMinute

Frequently Asked Questions

Is Scholar Rock Holding Corporation - Common Stock publicly traded?

Yes, Scholar Rock Holding Corporation - Common Stock is publicly traded.

What exchange does Scholar Rock Holding Corporation - Common Stock trade on?

Scholar Rock Holding Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Scholar Rock Holding Corporation - Common Stock?

The ticker symbol for Scholar Rock Holding Corporation - Common Stock is SRRK on the Nasdaq Stock Market

What is the current price of Scholar Rock Holding Corporation - Common Stock?

The current price of Scholar Rock Holding Corporation - Common Stock is 49.19

When was Scholar Rock Holding Corporation - Common Stock last traded?

The last trade of Scholar Rock Holding Corporation - Common Stock was at 05/12/26 04:00 PM ET

What is the market capitalization of Scholar Rock Holding Corporation - Common Stock?

The market capitalization of Scholar Rock Holding Corporation - Common Stock is 4.67B

How many shares of Scholar Rock Holding Corporation - Common Stock are outstanding?

Scholar Rock Holding Corporation - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.